PMC Articles for MedGen (Select 349383) - PMC

Links from MedGen

Items: 1 to 20 of 200

<< First< Prev

Page of 10

Select item 109394561.

Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium–glucose cotransporter 2 inhibitors

Paul J M Wijnker, Rafeeh Dinani, Nico C van der Laan, Sila Algül, Bjorn C Knollmann, Arie O Verkerk, Carol Ann Remme, Coert J Zuurbier, Diederik W D Kuster, Jolanda van der Velden

Cardiovasc Res. 2024 Feb; 120(3): 301–317. Published online 2024 Jan 18. doi: 10.1093/cvr/cvae004

PMCID:: PMC10939456

Article PDF–3.5M

Select item 109128152.

Altered myocardial lipid regulation in junctophilin-2–associated familial cardiomyopathies

Satadru K Lahiri, Feng Jin, Yue Zhou, Ann P Quick, Carlos F Kramm, Meng C Wang, Xander HT Wehrens

Life Sci Alliance. 2024 May; 7(5): e202302330. Published online 2024 Mar 4. doi: 10.26508/lsa.202302330

PMCID:: PMC10912815

Article PDF–3.1M

Select item 107328713.

Retracted: A Bioinformatic Approach Based on Systems Biology to Determine the Effects of SARS-CoV-2 Infection in Patients with Hypertrophic Cardiomyopathy

Computational and Mathematical Methods in Medicine

Comput Math Methods Med. 2023; 2023: 9769073. Published online 2023 Dec 13. doi: 10.1155/2023/9769073

Retracts:: Comput Math Methods Med. 2022; 2022: 5337380.

PMCID:: PMC10732871

Retraction PDF–454K

Select item 106962044.

Hypertrophic cardiomyopathy secondary to deficiency in lysosome-associated membrane protein-2: A case report

Ye-Tong Zhao, Xiu-Qun Cao, Xiao-Lin Mu

World J Cardiol. 2023 Nov 26; 15(11): 609–614. Published online 2023 Nov 26. doi: 10.4330/wjc.v15.i11.609

PMCID:: PMC10696204

Article PDF–2.7M

Select item 104756885.

Prognostic and Safety Implications of Renin-Angiotensin-Aldosterone System Inhibitors in Hypertrophic Cardiomyopathy: A Real-World Observation Over 2,000 Patients

Chan Soon Park, Tae-Min Rhee, Hyun Jung Lee, Yeonyee E. Yoon, Jun-Bean Park, Seung-Pyo Lee, Yong-Jin Kim, Goo-Yeong Cho, In-Chang Hwang, Hyung-Kwan Kim

Korean Circ J. 2023 Sep; 53(9): 606–618. Published online 2023 Jul 3. doi: 10.4070/kcj.2023.0035

PMCID:: PMC10475688

Article PDF–1.3M

Select item 103242756.

Dysregulated Rbfox2 produces aberrant splicing of Ca_V1.2 calcium channel in diabetes-induced cardiac hypertrophy

Pengpeng Li, Dongxia Qin, Tiange Chen, Wei Hou, Xinyu Song, Shumin Yin, Miaomiao Song, W.C. Hewith A. Fernando, Xiaojie Chen, Yu Sun, Juejin Wang

Cardiovasc Diabetol. 2023; 22: 168. Published online 2023 Jul 6. doi: 10.1186/s12933-023-01894-5

PMCID:: PMC10324275

Article PDF–8.4M

Select item 102951687.

The Junctophilin-2 Mutation p.(Thr161Lys) Is Associated with Hypertrophic Cardiomyopathy Using Patient-Specific iPS Cardiomyocytes and Demonstrates Prolonged Action Potential and Increased Arrhythmogenicity

Joona Valtonen, Chandra Prajapati, Reeja Maria Cherian, Sari Vanninen, Marisa Ojala, Krista Leivo, Tiina Heliö, Juha Koskenvuo, Katriina Aalto-Setälä

Biomedicines. 2023 Jun; 11(6): 1558. Published online 2023 May 27. doi: 10.3390/biomedicines11061558

PMCID:: PMC10295168

Article PDF–4.1M

Select item 102564458.

Discrimination of Traditional Chinese Medicine Syndromes in Type 2 Diabetic Patients Based on Metabolomics-Proteomics Profiles

Xin Shao, Gang Hu, Yuanyuan Lu, Ming Li, Baohua Shen, Wenwen Kong, Yanhua Guan, Xin Yang, Jia Fang, Jing Liu, Yingzhuo Ran

Int J Anal Chem. 2023; 2023: 5722131. Published online 2023 Jun 2. doi: 10.1155/2023/5722131

PMCID:: PMC10256445

Article PDF–2.1M

Select item 102113749.

Dual loss of regulator of G protein signaling 2 and 5 exacerbates ventricular myocyte arrhythmias and disrupts the fine-tuning of G_i/o signaling

Shelby A. Dahlen, Tyler F. Bernadyn, Alethia J. Dixon, Bo Sun, Jingsheng Xia, Elizabeth A. Owens, Patrick Osei-Owusu

J Mol Cell Cardiol. Author manuscript; available in PMC 2023 May 25.

Published in final edited form as: J Mol Cell Cardiol. 2022 Sep; 170: 34–46. Published online 2022 Jun 2. doi: 10.1016/j.yjmcc.2022.05.009

PMCID:: PMC10211374

Article PDF–2.2M

Select item 997173210.

Systematic investigation of the underlying mechanisms of GLP-1 receptor agonists to prevent myocardial infarction in patients with type 2 diabetes mellitus using network pharmacology

Guorong Deng, Jiajia Ren, Ruohan Li, Minjie Li, Xuting Jin, Jiamei Li, Jueheng Liu, Ya Gao, Jingjing Zhang, Xiaochuang Wang, Gang Wang

Front Pharmacol. 2023; 14: 1125753. Published online 2023 Feb 14. doi: 10.3389/fphar.2023.1125753

PMCID:: PMC9971732

Article PDF–2.7M

Select item 983662611.

The effect of Mg²⁺ on Ca²⁺ binding to cardiac troponin C in hypertrophic cardiomyopathy associated TNNC1 variants

K Rayani, ER Hantz, O Haji-Ghassemi, YA Li, AM Spuches, F Van Petegem, RJ Solaro, S Lindert, GF Tibbits

FEBS J. Author manuscript; available in PMC 2023 Dec 1.

Published in final edited form as: FEBS J. 2022 Dec; 289(23): 7446–7465. Published online 2022 Aug 2. doi: 10.1111/febs.16578

PMCID:: PMC9836626

Article PDF–1.3M

Select item 980458512.

Describing the natural history of clinical, biochemical and radiological outcomes of children with familial partial lipodystrophy type 2 (FPLD2) from the United Kingdom: A retrospective case series

Zhu Xuan Zhong, Julie Harris, Ellen Wilber, Samantha Gorman, David B. Savage, Stephen O'Rahilly, Anna Stears, Rachel M. Williams

Clin Endocrinol (Oxf) 2022 Dec; 97(6): 755–762. Published online 2022 Aug 17. doi: 10.1111/cen.14806

PMCID:: PMC9804585

Article PDF–554K

Select item 978069713.

Sodium-Glucose Co-transporter 2 Inhibitors/Gliflozins: A New Miracle Therapy for Heart Failure Patients Irrespective of Diabetes Status?

Paghunda Ehsan, Rawia N Aburumman, Shivani Ishwarya Muthanna, Swathi Radhakrishnan Menon, Vruti Vithani, Bansi Sutariya, Diana M Montenegro, Michael Chukwu, Sai Sri Penumetcha

Cureus. 2022 Nov; 14(11): e31777. Published online 2022 Nov 22. doi: 10.7759/cureus.31777

PMCID:: PMC9780697

Article PDF–572K

Select item 966390914.

2 Cases of Elusive Left Ventricular Outflow Tract Gradient

Alexandra Vaio Sykes, Elizabeth Epstein, Parnia Abolhassan Choubdar, Pam R. Taub

JACC Case Rep. 2022 Nov 2; 4(21): 1404–1408. Published online 2022 Nov 2. doi: 10.1016/j.jaccas.2022.07.023

PMCID:: PMC9663909

Article PDF–1.2M

Select item 953213915.

A Bioinformatic Approach Based on Systems Biology to Determine the Effects of SARS-CoV-2 Infection in Patients with Hypertrophic Cardiomyopathy

Xiao Han, Fei Wang, Ping Yang, Bin Di, Xiangdong Xu, Chunya Zhang, Man Yao, Yaping Sun, Yangyi Lin

Comput Math Methods Med. 2022; 2022: 5337380. Published online 2022 Sep 27. doi: 10.1155/2022/5337380

Retraction in:: Comput Math Methods Med. 2023; 2023: 9769073.

PMCID:: PMC9532139

Article

Select item 952231116.

Elevated angiotensin-converting enzyme 2 (ACE2) expression in cats with hypertrophic cardiomyopathy

Fabian Z.X. Lean, Simon L. Priestnall, Ana Gómez Vitores, Alejandro Suárez-Bonnet, Sharon M. Brookes, Alejandro Núñez

Res Vet Sci. 2022 Dec 20; 152: 564–568. doi: 10.1016/j.rvsc.2022.09.024

PMCID:: PMC9522311

Article

Select item 944365617.

Multisystem inflammatory syndrome in children (MIS-C) showing disseminated aspergillosis, cytomegalovirus reactivation and persistent SARS-COV-2: Case report with autopsy review

Mana Taweevisit, Ariya Chindamporn, Kritsaporn Sujjavorakul, Rujipat Samransamruajkit, Paul Scott Thorner

Pathol Res Pract. 2022 Oct; 238: 154106. Published online 2022 Sep 5. doi: 10.1016/j.prp.2022.154106

PMCID:: PMC9443656

Article PDF–11M

Select item 942398318.

Ca²⁺/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor of RIPK3 Protects against Cardiac Hypertrophy

Jingjing Zhang, Jianan Qian, Ji Cao, Xue Wang, Wei Zhang, Xiaosong Gu

Oxid Med Cell Longev. 2022; 2022: 7941374. Published online 2022 Jul 28. doi: 10.1155/2022/7941374

PMCID:: PMC9423983

Article PDF–8.5M

Select item 928874519.

Impact of SARS‐Cov‐2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry

Juan R. Gimeno, Iacopo Olivotto, Ana Isabel Rodríguez, Carolyn Y. Ho, Adrián Fernández, Alejandro Quiroga, Mari Angeles Espinosa, Cristina Gómez‐González, María Robledo, Lucas Tojal‐Sierra, Sharlene M. Day, Anjali Owens, Roberto Barriales‐Villa, Jose María Larrañaga, Jose Rodríguez‐Palomares, Maribel González‐del‐Hoyo, Jesús Piqueras‐Flores, Nosheen Reza, Olga Chumakova, Euan A. Ashley, Victoria Parikh, Matthew Wheeler, Daniel Jacoby, Alexandre C. Pereira, Sara Saberi, Adam S. Helms, Eduardo Villacorta, María Gallego‐Delgado, Daniel de Castro, Fernando Domínguez, Tomás Ripoll‐Vera, Esther Zorio‐Grima, José Carlos Sánchez‐Martínez, Ana García‐Álvarez, Elena Arbelo, María Victoria Mogollón, María Eugenia Fuentes‐Cañamero, Elias Grande, Carlos Peña, Lorenzo Monserrat, Neal K. Lakdawala, Dilema International Cardiomyopathy and Heart Failure Registry and international SHaRe (Sarcomeric Human Cardiomyopathy Registry) Investigators group

ESC Heart Fail. 2022 Aug; 9(4): 2189–2198. Published online 2022 Jun 3. doi: 10.1002/ehf2.13964

PMCID:: PMC9288745

Article PDF–1.5M

Select item 919758220.

Aerobic Exercise Inhibited P2X7 Purinergic Receptors to Improve Cardiac Remodeling in Mice With Type 2 Diabetes

Ting Wang, Jianmin Li, Hui Li, Xin Zhong, Luya Wang, Shujue Zhao, Xuesheng Liu, Zhouqing Huang, Yonghua Wang

Front Physiol. 2022; 13: 828020. Published online 2022 May 31. doi: 10.3389/fphys.2022.828020

PMCID:: PMC9197582

Article PDF–9.1M

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from MedGen

Items: 1 to 20 of 200

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity